We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ekf Diagnostics Holdings Plc | LSE:EKF | London | Ordinary Share | GB0031509804 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.35 | -1.08% | 32.20 | 32.20 | 32.90 | 32.20 | 32.20 | 32.20 | 66,041 | 16:28:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 52.61M | 2.35M | 0.0052 | 61.92 | 146.49M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/9/2020 12:53 | Presentation as well as results very excited as to what they have to say time to load up in my view | retirementfund | |
10/9/2020 12:23 | retirementfund It looks like you will have to wait until Monday! | mirandaj | |
10/9/2020 11:03 | As always great research Wan second have is going to massively exceed expected results in my view. Bring on the news | retirementfund | |
10/9/2020 09:22 | As we enter the flu season some of the increased testing and new testing capacity will also be driven by the need to differentiate between COVID-19, RSV, and influenza A and B. Diagnostic companies are already launching, and about to launch an array of multiplex tests to accommodate the potential surge in patients seeking such diagnoses. Leaked details from the BMJ regarding the UK's direction of travel in terms of vastly increased testing capacity efforts - EXCLUSIVE Covid-19: Government plans to spend £100bn on expanding testing to 10 million a day BMJ 2020; 370 doi: hxxps://doi.org/10.1 Published 09 September 2020 The UK government has drawn up plans to carry out up to 10 million covid-19 tests a day by early next year as part of a huge £100bn (€110bn; $130bn) expansion of its national testing programme, documents seen by The BMJ show. The internal correspondence reveals that the government is prepared to almost match what it spends on the NHS in England each year (£130bn) to fund mass testing of the population “to support economic activity and a return to normal life” under its ambitious Operation Moonshot programme. A briefing memo sent to the first minister and cabinet secretaries in Scotland, seen by The BMJ, says that the UK-wide Moonshot programme is expected to “cost over £100bn to deliver.” If achieved, the programme would allow testing of the entire UK population each week. A separate PowerPoint presentation prepared for the government by the global management consulting firm Boston Consulting Group, also seen by The BMJ, says the plans had the potential to grow the UK’s testing capacity from the current 350 000 a day to up to 10 million tests a day by early 2021. The Whitehall briefing document says that success depends on scaling up polymerase chain reaction (PCR) testing but also on emerging technologies, such as the “20 minute” saliva tests currently being piloted in Salford, Greater Manchester. The expansion will require “developing, validating, procuring, and operationalising testing technology that currently does not exist” and “creating significant new logistical and manufacturing infrastructure and capacity.” Full article - | wan | |
10/9/2020 08:19 | The scale of testing which needs to be carried out is truly staggering this can only be positive for EKF. Results Monday makes sense current trading update is going to be very exciting. in my own opinion | retirementfund | |
10/9/2020 07:45 | Grant Shapps currently talking on the BBC referred to the possibility (subject to test technology) of individuals getting tested every day. 200 Million Monthly COVID-19 Tests Needed in US, Report Says Sep 09, 2020 NEW YORK ─ To open safely and in stages, a US nationwide screening strategy will require about 200 million tests each month for students and staff at the nation’s primary and secondary schools, as well as residents and staff at nursing homes, according to a report released on Wednesday. The report, titled A National Decision Point: Effective Testing and Screening for COVID-19, was produced by Duke University’s Margolis Center for Health Policy, based in Durham, North Carolina, with funding from New York-based Rockefeller Foundation. | wan | |
10/9/2020 07:36 | Everywhere I look COVID-19 testing capacity is being significantly ramped-up. Plus various rapid tests are in development, or being launched. The global testing capacity and supply chain requirement,from laboratory tests, to nearer the test setting/POC and saliva testing, is truly massive and on an unprecedented scale! I firmly believe that PrimeStore MTM will have good exposure to the current and emerging testing requirements, and across a spectrum of tests, not just today's lab tests that governments have, and still are, rapidly scaling. An example of how PrimeStore is likely to feature in a wider spectrum of testing, and no guarantee that this is PrimeStore related, is a newly launched saliva test from Halo that is 'beyond' current government efforts (not unsurprising some might say!) - Halo overcomes the need for nasal swabs or blood tests with cutting-edge saliva testing technology. This makes our sample collection safer, non-invasive and more sensitive. Our collection tubes contain a liquid which rapidly deactivates viral proteins while preventing genetic material from degrading, making it non-infectious and stable for days - | wan | |
10/9/2020 07:15 | I take it EKF is on the above list? | cravencottage | |
09/9/2020 20:41 | There must be quite a lot going on behind the scenes.. Perhaps no time for an annoucement as and when results will be published/ Albeit we're told they're in the first half of September. Looking forward to gathering the BOD's latest thoughts! | cravencottage | |
09/9/2020 18:15 | According to factset results are out in the 14th | gonjon | |
09/9/2020 13:58 | 10 September last year | donald pond | |
09/9/2020 13:35 | Given today's trades very surprised this has gone up results must be super close in my view | retirementfund | |
08/9/2020 12:10 | Those 66.6% will be so glad that tests can accurately tell whether they have flu or COVID-19. | wan | |
08/9/2020 12:02 | ...and that too Wan | marvelman | |
08/9/2020 11:45 | ...They will likely want routine and frequent testing | wan | |
08/9/2020 11:42 | ...many will die | marvelman | |
08/9/2020 11:32 | buywell sees a small problem 66.6% of Yanks are NOT going to take a vaccine shot What happens then ? | buywell3 | |
08/9/2020 11:25 | That is a very recent addition!.....Nice spot Mirandaj | wan | |
08/9/2020 11:06 | It would be good to have news section updated and this will be interesting going forward: PrimeStore ATM® A virucidal, bacteriostatic, Guanidine-free sample collection device optimized for molecular testing while providing highly sensitive antigen testing capabilities. Accepting orders* beginning August 27, 2020 for Research Use Only. Initial EUA using PrimeStore ATM expected to be filed in Early September. | mirandaj | |
08/9/2020 10:29 | Previously I have provided food for thought, along with the scientific evidence and links, providing good evidence that PrimeStore MTM could enhance, possibly enable, certain tests including RT-LAMP saliva tests and the importance of differentiating between flu and Covid-19. And that going forwards, given the attributes of PrimeStore MTM, I was also interested to see if PrimeStore MTM might be paired with, or have preference with certain diagnostic developers/tests. Implying - in the future - that use of PrimeStore MTM for COVID-19 testing could significantly increase via use across a wider spectrum of the global testing. The following interview with Longhorns President provides some important insights, including confirmation that Longhorn are working with government agencies and some very large companies to scale production and distribution, including that they are working with one of the largest diagnostic companies in the world to add PrimeStore MTM to their point of care test that differentiates between COVID-19 and flu - | wan | |
07/9/2020 11:24 | They have this 100% correct EKF has establishing a very significant position the CV19 is thought to be all about a short to cash injection this is going to provide very significant income for a long time. With the results which should contain a further trading update and confirmation of further orders. in my opinion | retirementfund | |
05/9/2020 23:35 | Texchinvest- lengthy article on Ekf again, keep buying | malcolmmm | |
05/9/2020 13:22 | Thanks Hastings, I look forward to that. | wan |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions